Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, US Genomics

Premium

Sigma-Aldrich recently announced that it has released new additions to its Mission TRC RNAi product line. These additions bring the current number of vector constructs offered to 50,000, targeting 7,100 human and 2,900 mouse genes, the company said.

The constructs are available as frozen bacterial glycerol stocks or transfection grade plasmid DNA, Sigma-Aldrich said.

Additional information about the Mission RNAi products can be found at http://www.sigmaaldrich.com/Area_of_Interest/Life_Science/RNA_Interference_RNAi.html.


US Genomics has recently unveiled its Direct Results fee-for-service program, which allows researchers to use single molecule technology to accurately quantitate the microRNAs in their samples.

According to the company, the new service uses the Trilogy 2020 single molecule analyzer to enable scientists to detect individual molecules of miRNA with Direct miRNA assays.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.